Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.

What factors are associated with a woman's decision to take hormone replacement therapy? Evaluated in the context of a decision aid. Health Expect (2003) 0.84

Validation of a decision model for preventive pharmacological strategies in postmenopausal women. Eur J Epidemiol (2005) 0.76

Osteoporosis. CMAJ (1997) 0.75

Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA (1991) 3.07

Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med (1991) 2.77

Bone gain in young adult women. JAMA (1992) 2.73

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1995) 2.58

Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA (1983) 2.57

Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA (1990) 2.45

Postmenopausal estrogen and prevention bias. Ann Intern Med (1991) 2.31

Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet (1990) 2.00

The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol (1984) 1.80

Effects of various types and dosages of progestogens on the postmenopausal endometrium. J Reprod Med (1982) 1.07

Efficacy of a continuous estrogen-progestin regimen in the menopausal patient. Obstet Gynecol (1987) 1.03

Continuous estrogen/progestin therapy in menopause. Am J Obstet Gynecol (1987) 1.02

Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am J Med (1994) 1.02

A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium. Obstet Gynecol (1989) 0.84

Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin. J Reprod Med (1988) 0.83

Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism. Arch Intern Med (1992) 0.82